Request Trial
jackie-7
26 November 2020Muireann Bolger

Five minutes with… Jacqueline Mulryne

Amid the unprecedented challenges presented by COVID-19, questions around the use of second medical use (SMU) patents have become increasingly pertinent. On Tuesday December 1, LSPN Connect ’s session: Addressing Second Medical Use Infringement: An Evaluation of Recent SMU Cases will examine a number of key issues relating to this pivotal area of life sciences IP.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Regulation & Industry
UK appoints ex-engineer as new intellectual property Minister
24 August 2026   Labour MP for Stockton North takes up a new role as Minister for Science, Innovation and Investment within Andy Burnham’s government.
Careers
Stris & Maher opens new Dallas office with partner hires
24 August 2026   The four-person team adds significant life sciences experience to the litigation boutique, drawn to move firms by Stris’ “outstanding trial lawyers” and “sophisticated appellate capabilities”.
Pharma
Teva and Aurinia settle generics dispute over lupus drug, voclosporin
21 August 2026   Under the terms of the agreement, which resolves all patent litigation between the biopharma rivals, Teva now has a launch date for its own version of Aurinia's Lupkynis.


Editor's picks

Abbott fends off Chinese rival’s patent challenge at UPC
MedTech
Abbott fends off Chinese rival’s patent challenge at UPC
18 August 2026

Editor's picks

MedTech
Abbott fends off Chinese rival’s patent challenge at UPC
18 August 2026
Regulation & Industry
Buying the brains: Why is Big Pharma shopping for innovation?
27 July 2026
Regulation & Industry
Why is 2026 already a record year for M&A activity?
17 July 2026
Biotech
Sanofi launches mRNA vaccine lawsuits at Moderna and Pfizer
15 July 2026
Pharma
What’s at stake in Australia’s biggest pharma patent appeal in years?
1 July 2026
Biotech
Pfizer’s US Paxlovid patent fight turns on a single error
25 June 2026

More features

UK appoints ex-engineer as new intellectual property Minister
Stris & Maher opens new Dallas office with partner hires
Teva and Aurinia settle generics dispute over lupus drug, voclosporin
10x Genomics dealt major blow in sequencing fight
SK Biopharmaceuticals settles epilepsy generic dispute
Vanda revives challenge over braille-free label on generic sleep disorder drug
Abbott fends off Chinese rival’s patent challenge at UPC
Former head of litigation at Nokia returns to Bird & Bird